ClinicalTrials.Veeva

Menu

Optimal Timing For Embryo Transfer For Low Responder Patients

H

HaEmek Medical Center, Israel

Status

Terminated

Conditions

Infertility

Treatments

Other: Embryo Transfer

Study type

Interventional

Funder types

Other

Identifiers

NCT01040247
0027-09-EMC

Details and patient eligibility

About

Women undergoing in vitro fertilization (IVF) therapy, who are low responder and agree to enter the trial will be randomized to a study group, for whom embryo transfer will be done on the same day as oocyte aspiration and fertilization; and a control group for whom embryo transfer will be performed 48 to 72 hours later, as is the current accepted practice.

Enrollment

20 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient undergoing IVF
  • Number of mature oocytes equal to or lesser than the maximum number of embryos intended for transfer

Exclusion criteria

  • Patient nor consenting

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 2 patient groups

Day 0 Embryo Transfer
Experimental group
Description:
Embryo transfer will be performed on the same day as oocyte aspiration and fertilization
Treatment:
Other: Embryo Transfer
Day 2,3 Embryo Transfer
Active Comparator group
Description:
Embryo Transfer will be performed 2 or 3 days after oocyte aspiration and fertilization
Treatment:
Other: Embryo Transfer

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems